Document is current
Any future updates will be listed below
-
Authors
Mak, Joyce W. Y.
Sun, Yang
Limsrivilai, Julajak
Abdullah, Murdani
Kaibullayeva, Jamilya
Balderramo, Domingo
Vergara, Beatriz Iade
Paudel, Mukesh Sharma
Banerjee, Rupa
Hilmi, Ida
Ali, Raja Affendi Raja
Wei, Shu Chen
Ng, Ka Kei
Altuwaijri, Mansour
Kelly, Paul
Yamamoto-Furusho, Jesus K.
Kotze, Paulo Gustavo
Ahuja, Vineet
Chong, Vui Heng
Dao, Hang Viet
Abbey, Yvonne
Ching, Jessica Y. L.
Ho, Agnes
Chan, Alicia K. W.
Bernstein, Charles N.
Gearry, Richard B.
Abreu, Maria
Rubin, David T.
Dotan, Iris
Hracs, Lindsay
Kaplan, Gilaad G.
Ng, Siew C.
,
Tao, Yan
Rong, Jiamei
Chen, Xiaocui
Song, Huixian
Zhou, Chan
Mu, Yanju
Wei, Wenjuan
Bai, Xinyu
Aniwan, Satimai
Kitiyakara, Taya
Harinwan, Kamin
Bunchorntavakul, Chalermrat
Techathuvanan, Karjpong
Kijdamrongthum, Phuripong
Suttichaimongkol, Tanita
Wetwittayakhlang, Panu
Simadibrata, Marcellus
Syam, Ari Fahrial
Larasati, Deka
Tedjasaputra, Tjahjadi Robert
Saragih, Arlyando Hezron
Koncoro, Hendra
Kanabayeva, Aizhan
Kongyrbayeva, Nazira
Kurmangaliyeva, Assem
Laryushina, Yelena
Perizat, Toktarova
Venera, Ayupova
Aidana, Kaliyakparova
Toscani, Ignacio
Nicoloff, Luciana
Howe, Marie
Khoo, Xin Hui
Heng, Wong Choon
Singh, Harjinder
Chua, Andrew
Hong, Khong Wai
Weng, Meng-Tzu
Lin, Wei-Chen
Lee, Hsi-Chang
Chang, Chun-Chao
Lin, Chun-Chi
Le, Puo Hsien
Huang, Tien-Yu
Sun, Cheuk-Kay
Yeh, Hsing-Jung
Ho, Yu Hon
AlIbrahim, Bashaar
Alahmari, Mohammed
Hodges, Phoebe
Nsokolo, Bright
Awuku, Yaw
Li, Michael
Chan, Kam Hon
Man, Yip Wai
Yun-Sze, Thomas Wong
Fong, Alex
-
Funding
Funding for this research was provided by:
Leona M. and Harry B. Helmsley Charitable Trust (G-2106-04697)
- License Information
-
More Information
Article History
Received: 17 January 2023
Accepted: 10 May 2023
First Online: 25 May 2023
Declarations
:
: The Joint Chinese University of Hong Kong New Territories East Cluster Clinical Research Ethics Committee approved this study (2020.574). All recruited subjects gave written consent. Recruitment of subjects and data collection was managed by trained and experienced research staff. Data were stored in a study-specific, secured online database and would be adequately protected to maintain security and privacy. The database contained different pre-defined levels of researcher access.This study is conducted in compliance with Declaration of Helsinki and ICH-GCP guidelines.
: Not applicable.
: Dr. Ng has received honoraria for speaking or consultancy for Janssen, Abbvie, Takeda, Ferring, Tilotts, Menarini, Pfizer. She has received research support from Olympus, Ferring, Janssen and Abbvie.Dr. Kaplan has received honoraria for speaking or consultancy from AbbVie, Janssen, Pfizer,91 Amgen, and Takeda. He has received research support from Ferring, Janssen, AbbVie, Glaxo Smith Kline, Merck, and Shire. He has been a consultant for Gilead. He shares ownership of a patent: TREATMENT OF INFLAMMATORY DISORDERS, AUTOIMMUNE DISEASE, AND PBC. UTI Limited Partnership, assignee. Patent WO2019046959A1. PCT/CA2018/051098. 7 Sept. 2018.Dr. Bernstein is supported by the Bingham Chair in Gastroenterology. Dr. Bernstein has served on advisory Boards for AbbVie Canada, Amgen Canada, Bristol Myers Squibb Canada, Roche Canada, JAMP Pharmaceuticals Canada, Janssen Canada, Sandoz Canada, Takeda Canada, and Pfizer Canada; Consultant for Mylan Pharmaceuticals and Takeda; Educational grants from Abbvie Canada, Bristol Myers Squibb Canada \, Pfizer Canada, Takeda Canada, and Janssen Canada. Speaker’s panel for Abbvie Canada, Janssen Canada, Pfizer Canada, and Takeda Canada. Received research funding from Abbvie Canada and, Amgen Canada, Sandoz Canada, Takeda Canada, Pfizer Canada.Dr. Kotze has received speaking and consultancy honorarium from Pfizer, Janssen, Takeda, Abbvie and Novartis. He also received scientific grants from Takeda and PfizerDr. Gearry has received honoraria, consultancy, or research grants from AbbVie, Janssen, Celltrion, Takeda, Ferring and Zespri.Dr. Yamamoto-Furusho has consulted or served on advisory boards for: AbbVie, Bristol Myers Squibb, Boehringer Ingelheim, Ferring pharmaceutical, Janssen, Pfizer and Takeda; Teaching, lecturing, or speaking: Abbvie, Carnot, Celltrion, Schering-Plough, Falk foundation, Ferring, Janssen, MSD, Pfizer, Takeda, UCB, Grants/Research Support: Shire, Bristol Myers, Celgene, Takeda.Dr. Shu Chen Wei has consulted or served on advisory boards for: AbbVie, Celltrion, Ferring.Pharmaceuticals Inc., Gilead, Janssen, Pfizer, Takeda, and Tanabe and receives lecture fees from AbbVie, Bristol Myers Squibb, Celltrion, Excelsior Biopharma Inc., Ferring Pharmaceuticals Inc., Janssen, Takeda, Tanabe.Dr. Paulo G. Kotze has received speaking and consultancy honorarium from Pfizer, Janssen, Takeda, AbbVie, and Novartis, and also has received scientific grants from Takeda and Pfizer.Dr. Maria T. Abreu has consulted or served on advisory boards or as a consultant for AbbVie Inc, Arena Pharmaceuticals, Bristol Myers Squibb, Celsius, Eli Lilly Pharmaceuticals, Gilead, Helmsley Charitable Trust, Janssen, Microba, Pfizer, Prometheus Biosciences, UCB Biopharma, WebMD Global LLC and has served as a speaker for Alimentiv, Janssen, Prime CME, and Takeda Pharmaceuticals.Dr. David Rubin has received grant support from Takeda, and has served as a consultant for Abbvie, Altrubio, Aslan Pharmaceuticals, Athos Therapeutics, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Ltd., Bristol-Myers Squibb, Celgene Chronicles, Corp/Syneos, ClostraBio, Connect BioPharma, Eco R1, Genentech/Roche, Gilead Sciences, Iterative Health, Janssen Pharmaceuticals, Kaleido Biosciences, Lilly, Pfizer, Prometheus Biosciences, Reistone, Seres Therapeutics, Takeda, Target RWE, and Trellus Health.Dr. Iris Dotan has received grant support from BMS and Altman Research and has served as a consultant/advisor/speaker to Abbvie, Abbott, Athos, Arena, BMS/Celgene, Celltrion, Cambridge Healthcare, Eli-Lilly, Falk Pharma, Food Industries Organization, Gilead, Galapagos, Genentech/Roche, Iterative Scopes, Integra Holdings, Janssen, Neopharm, Pfizer, Rafa Laboratories, Sublimity, Sangamo, Takeda, Wilbio, Dr. Panu Wetwittayakhlang M.D. has been a speaker and/or advisory board member: Takeda, Pfizer, Janssen, Ferring, A. Menerini, and MSD.No conflict of interests for other authors.
